Jointechlabs Inc. (JTL) desires to be the worldwide leader in point-of-care regenerative medicine therapies. Our FDA approved device MiniTC, and CE Mark pending Mini-Stem system enable healthcare practitioners and hospitals worldwide to provide safe, reliable, cost-effective non-surgical interventional medicine treatments at the point-of-care without significant change in infrastructure. Our devices are patented, disposable, and closed loop that can isolate cell enriched fat grafts (also called nanofat) and stem cell fraction (SVF) from fat. Our pipeline products are FDA approvable stem cell therapies based on our technology for indications with unmet medical needs.